Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation

Sunil Kumar; Amritha Manoharan; Jayalakshmi J; Mohamed A. Abdelgawad; Wael A. Mahdi; Sultan Alshehri; Mohammed M. Ghoneim; Leena K. Pappachen; Subin Mary Zachariah; T. P. Aneesh; Bijo Mathew

doi:10.1039/D3RA90030D

Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation

Sunil Kumar,^a Amritha Manoharan,^a Jayalakshmi J,^a Mohamed A. Abdelgawad,^bc Wael A. Mahdi,^d Sultan Alshehri,^d Mohammed M. Ghoneim,^ef Leena K. Pappachen,^a Subin Mary Zachariah,^a T. P. Aneesh*^a and Bijo Mathew*^a

Author affiliations

* Corresponding authors

^a Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, India
E-mail: bijomathew@aims.amrita.edu, bijovilaventgu@gmail.com, aneeshtp@aims.amrita.edu

^b Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Saudi Arabia

^c Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt

^d Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia

^e Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Ad Diriyah, Saudi Arabia

^f Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt

Abstract

Correction for ‘Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation’ by Sunil Kumar et al., RSC Adv., 2023, 13, 9513–9529, https://doi.org/10.1039/D3RA00526G.

RSC Advances

Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation

Social activity

Search articles by author

Spotlight

Advertisements